Annual SGA
$73.32 M
+$14.54 M+24.75%
December 31, 2023
Summary
- As of February 8, 2025, RCKT annual SGA is $73.32 million, with the most recent change of +$14.54 million (+24.75%) on December 31, 2023.
- During the last 3 years, RCKT annual SGA has risen by +$44.45 million (+154.00%).
- RCKT annual SGA is now at all-time high.
Performance
RCKT SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$27.11 M
-$258.00 K-0.94%
September 30, 2024
Summary
- As of February 8, 2025, RCKT quarterly SGA is $27.11 million, with the most recent change of -$258.00 thousand (-0.94%) on September 30, 2024.
- Over the past year, RCKT quarterly SGA has increased by +$8.52 million (+45.86%).
- RCKT quarterly SGA is now -0.94% below its all-time high of $27.37 million, reached on June 30, 2024.
Performance
RCKT Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$4.23 B
-$258.08 M-6.50%
September 30, 2024
Summary
- As of February 8, 2025, RCKT TTM SGA is -$4.23 billion, with the most recent change of -$258.08 million (-6.50%) on September 30, 2024.
- Over the past year, RCKT TTM SGA has dropped by -$4.30 billion (-6071.81%).
- RCKT TTM SGA is now -3469.03% below its all-time high of -$118.51 million.
Performance
RCKT TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
RCKT Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.8% | +45.9% | -6071.8% |
| 3 y3 years | +154.0% | +45.9% | -6071.8% |
| 5 y5 years | +309.9% | +45.9% | -6071.8% |
RCKT Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +75.5% | -0.9% | +139.6% | -148.8% | at low |
| 5 y | 5-year | at high | +301.9% | -0.9% | +375.9% | -586.9% | at low |
| alltime | all time | at high | +5437.5% | -0.9% | >+9999.0% | -3469.0% | at low |
Rocket Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $27.11 M(-0.9%) | $98.16 M(+9.5%) |
| Jun 2024 | - | $27.37 M(+23.6%) | $89.64 M(+12.5%) |
| Mar 2024 | - | $22.15 M(+2.8%) | $79.64 M(+8.6%) |
| Dec 2023 | $73.32 M(+24.7%) | $21.54 M(+15.9%) | $73.32 M(+3.5%) |
| Sep 2023 | - | $18.59 M(+7.0%) | $70.83 M(+5.2%) |
| Jun 2023 | - | $17.37 M(+9.8%) | $67.35 M(+7.2%) |
| Mar 2023 | - | $15.82 M(-16.9%) | $62.83 M(+6.9%) |
| Dec 2022 | $58.77 M(+40.7%) | $19.05 M(+26.1%) | $58.77 M(+15.1%) |
| Sep 2022 | - | $15.11 M(+17.5%) | $51.05 M(+11.1%) |
| Jun 2022 | - | $12.85 M(+9.2%) | $45.97 M(+7.8%) |
| Mar 2022 | - | $11.77 M(+4.0%) | $42.63 M(+2.1%) |
| Dec 2021 | $41.77 M(+44.7%) | $11.32 M(+12.9%) | $41.77 M(+5.5%) |
| Sep 2021 | - | $10.03 M(+5.3%) | $39.60 M(+12.2%) |
| Jun 2021 | - | $9.52 M(-12.8%) | $35.31 M(+8.2%) |
| Mar 2021 | - | $10.91 M(+19.3%) | $32.62 M(+13.0%) |
| Dec 2020 | $28.86 M(+58.2%) | $9.14 M(+59.6%) | $28.87 M(+13.6%) |
| Sep 2020 | - | $5.73 M(-16.1%) | $25.42 M(+5.8%) |
| Jun 2020 | - | $6.83 M(-4.7%) | $24.02 M(+11.2%) |
| Mar 2020 | - | $7.16 M(+25.7%) | $21.60 M(+18.4%) |
| Dec 2019 | $18.24 M | $5.70 M(+31.4%) | $18.24 M(+18.4%) |
| Sep 2019 | - | $4.34 M(-1.5%) | $15.41 M(+15.5%) |
| Jun 2019 | - | $4.40 M(+15.6%) | $13.34 M(+2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $3.81 M(+32.9%) | $13.04 M(-27.1%) |
| Dec 2018 | $17.89 M(+42.6%) | $2.87 M(+26.3%) | $17.89 M(-26.8%) |
| Sep 2018 | - | $2.27 M(-44.7%) | $24.46 M(+1.8%) |
| Jun 2018 | - | $4.10 M(-52.7%) | $24.02 M(+16.5%) |
| Mar 2018 | - | $8.66 M(-8.1%) | $20.62 M(+64.4%) |
| Dec 2017 | $12.54 M(+26.8%) | $9.43 M(+414.8%) | $12.54 M(+113.9%) |
| Sep 2017 | - | $1.83 M(+160.8%) | $5.86 M(-7.6%) |
| Jun 2017 | - | $702.00 K(+20.0%) | $6.34 M(-20.3%) |
| Mar 2017 | - | $585.00 K(-78.7%) | $7.96 M(-19.6%) |
| Dec 2016 | $9.89 M(+26.2%) | $2.75 M(+18.8%) | $9.89 M(+4.6%) |
| Sep 2016 | - | $2.31 M(-0.2%) | $9.46 M(+5.4%) |
| Jun 2016 | - | $2.31 M(-8.2%) | $8.97 M(+7.0%) |
| Mar 2016 | - | $2.52 M(+9.2%) | $8.38 M(+6.9%) |
| Dec 2015 | $7.84 M(+271.3%) | $2.31 M(+26.5%) | $7.84 M(+24.3%) |
| Sep 2015 | - | $1.82 M(+5.6%) | $6.31 M(+18.4%) |
| Jun 2015 | - | $1.73 M(-12.7%) | $5.33 M(+35.5%) |
| Mar 2015 | - | $1.98 M(+155.5%) | $3.93 M(+86.1%) |
| Dec 2014 | $2.11 M(+59.5%) | $775.00 K(-8.1%) | $2.11 M(+48.8%) |
| Sep 2014 | - | $843.00 K(+153.9%) | $1.42 M(+146.4%) |
| Jun 2014 | - | $332.00 K(+104.9%) | $576.00 K(+136.1%) |
| Mar 2014 | - | $162.00 K(+97.6%) | $244.00 K(+197.6%) |
| Dec 2013 | $1.32 M(-42.6%) | $82.00 K | $82.00 K |
| Dec 2012 | $2.31 M | - | - |
FAQ
- What is Rocket Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals annual SGA year-on-year change?
- What is Rocket Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals quarterly SGA year-on-year change?
- What is Rocket Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Rocket Pharmaceuticals?
- What is Rocket Pharmaceuticals TTM SGA year-on-year change?
What is Rocket Pharmaceuticals annual SGA?
The current annual SGA of RCKT is $73.32 M
What is the all time high annual SGA for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high annual SGA is $73.32 M
What is Rocket Pharmaceuticals annual SGA year-on-year change?
Over the past year, RCKT annual SGA has changed by +$14.54 M (+24.75%)
What is Rocket Pharmaceuticals quarterly SGA?
The current quarterly SGA of RCKT is $27.11 M
What is the all time high quarterly SGA for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high quarterly SGA is $27.37 M
What is Rocket Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, RCKT quarterly SGA has changed by +$8.52 M (+45.86%)
What is Rocket Pharmaceuticals TTM SGA?
The current TTM SGA of RCKT is -$4.23 B
What is the all time high TTM SGA for Rocket Pharmaceuticals?
Rocket Pharmaceuticals all-time high TTM SGA is -$118.51 M
What is Rocket Pharmaceuticals TTM SGA year-on-year change?
Over the past year, RCKT TTM SGA has changed by -$4.30 B (-6071.81%)